Abbott Laboratories (ABT) vs Edwards Lifesciences Corporation (EW)
- Abbott Laboratories ABT 104.88 +0.19%
- Edwards Lifesciences Corporation EW 86.60 −1.70%
Abbott Laboratories and Edwards Lifesciences Corporation are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $181.1B against $50.8B — 3.6× the size. Abbott Laboratories trades at the lower P/E: 33.9× against 49.8×. Edwards Lifesciences Corporation grew revenue faster over the last twelve months: 14.6% against 8.06%. Edwards Lifesciences Corporation has the higher net margin (15.4% vs 11.7%) and the higher return on invested capital (12.8% vs 5.83%). Across the 22 metrics below, Abbott Laboratories leads on 11 and Edwards Lifesciences Corporation on 11.
Valuation
Profitability
| Metric | ABT | EW | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.61% | 77.84% | 56.01% |
| Operating margin | 15.77% | 22.25% | (15.03%) |
| Net margin | 11.65% | 15.43% | (20.40%) |
| Free cash flow margin | 16.80% | 22.01% | (7.24%) |
| Return on equity | 10.58% | 9.42% | (15.32%) |
| Return on assets | 5.62% | 7.35% | (19.72%) |
| Return on invested capital | 5.83% | 12.81% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack